Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
United Kingdom | Publication | December 2022
The Regulator has published additional information on completing their 2023 scheme returns for DB and hybrid schemes.
The main change is the questions in the asset breakdown section to reflect the outcome of the Regulator’s 2021 consultation with the PPF. Asset information will be tier-based, depending on the size of the scheme’s total liabilities:
Schemes in Tiers 2 and 3 will need to provide information about their bond and equities holdings. Schemes in Tier 3 will also need to provide information on risk factor stresses.
The update includes sample scheme returns for both DB and hybrid schemes. Schemes will receive their return notices from February 1, 2023, with the submission deadline being March 31, 2023.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025